Elocon and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Loraz (lorazepam). Common drug interactions include abasia among females and basophil count increased among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Loraz. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.



On Jul, 12, 2026

32 people who take Elocon and Loraz together, and have interactions are studied.

Elocon and Loraz drug interactions.

What are the common drug interactions of Elocon and Loraz, by gender? *:

female:

  1. Abasia (inability to walk)
  2. Abdominal discomfort
  3. Abdominal pain
  4. Adverse event
  5. Anaemia of chronic disease
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Aortic calcification (aortic calcification sign of heart valve disease)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Arthralgia (joint pain)

male:

  1. Basophil count increased
  2. Blood sodium decreased
  3. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  4. Oxygen saturation decreased
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Pneumonia
  7. Pruritus (severe itching of the skin)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Rash erythematous (redness of the skin)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Elocon and Loraz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac arrest
  2. Colitis (inflammation of colon)
  3. Death
  4. Hypotension (abnormally low blood pressure)
  5. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

n/a

50-59:

  1. Pulmonary congestion (congestion in the lungs)
  2. Pyrexia (fever)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Fatigue (feeling of tiredness)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
  7. Rash
  8. Asthma
  9. Diabetes mellitus non-insulin-dependent
  10. Flushing (the warm, red condition of human skin)

60+:

  1. Haemoglobin decreased
  2. Basophil count increased
  3. Cough
  4. Pain
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Abdominal distension
  7. Chest discomfort
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Constipation
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Agitation (state of anxiety or nervous excitement): 5 people, 15.62%
  2. Rashes (redness): 5 people, 15.62%
  3. Constipation: 5 people, 15.62%
  4. Insomnia (sleeplessness): 5 people, 15.62%
  5. Asthma: 4 people, 12.50%
  6. Pain: 4 people, 12.50%
  7. Neuropathy Peripheral (surface nerve damage): 4 people, 12.50%
  8. Delirium (wild excitement): 4 people, 12.50%
  9. Depression: 4 people, 12.50%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Loraz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elocon and Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elocon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and lorazepam (the active ingredients of Elocon and Loraz, respectively), and Elocon and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: